Company |
Amount Raised |
Salix Pharmaceuticals (March) |
$690M |
Elan Corp. plc (March) |
$381M |
Theravance Inc. (April) |
$212.9M |
Amarin Corp. plc (January) |
$150M |
Vernalis plc (February) |
$103.8M |
ThromboGenics NV (March) |
$103.2M |
Horizon Pharma (March) |
$50.8M |
Algeta ASA (February) |
$45.4M |
Cytos Biotechnology (March) |
$40.6M |
Aastrom Biosciences (March) |
$40M |